HALKUFF DAWN purchased 5.41K shares of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market purchase worth $10.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/21/2023ACC: 0001867096-23-000151
Director
Since Oct 2021
+5.41K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5.41K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+5.41K
Price / share
$1.84
Trade value
$9.95K
% of position
New position
11/20/2023
0.00→5.41K
Total
Net shares
+5.41K
Net value
$9.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/20/2023 | P · Purchase | +5.41K | $1.84 | $9.95K | New position | 0.00 | 5.41K |
| Total | +5.41K | $9.95K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned57.50K
Total
57.50K direct57.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 57.50K | Direct |
| Total | 57.50K | 57.50K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported